AltruBio
Drug DiscoveryWebsite
Developer of first-in-class immune-modulators to target diseases of the immune system. The company has clinically validated a first-in-class immune checkpoint regulator mechanism to selectively target...
Valuation
$0
Share Price
N/A
Total Raised
$336.6M
Last Round
Later Stage VC (Series B)
May 2024
Latest Funding Round
Later Stage VC (Series B)
May 21, 2024
$225M
raised
Investors
+10 other investors